- Home
- / CG Oncology
CG Oncology
Stock Price
$36.2
2024-10-29
Market Capitalization
$2.5 B
2024-10-29
Revenue
$4 M
FY, 2025
CG Oncology Summary
Company Summary
- Overview
- CG Oncology (formerly known as Cold Genesys) is an oncolytic immunotherapy company. It is focused on the research, acquisition, and development of therapeutics for patients with bladder cancer.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Irvine, CA, US | view all locations
- Website
- https://cgoncology.com/
- Cybersecurity rating
Table of Contents
Key People
Vijay Kasturi, Chief Medical Officer
Ambaw Bellete, President and Chief Operating Officer
Swapnil Bhargava, Chief Technical Officer
LocationsView all
2 locations detected
Irvine, CA HQ
United States
400 Spectrum Center Dr Suite 2040
Emeryville, CA
United States
1900 Powell St #800
CG Oncology Financials
Summary Financials
- Revenue (Q1, 2026)
- $1.1M
- Net income (Q1, 2026)
- ($60.2M)
- Cash (Q1, 2026)
- $33.7M
- EBIT (Q1, 2026)
- ($66.4M)
- Enterprise value
- $2.5B